Alpine Immune Sciences, Inc. ALPN
64.97 +64.97
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 58.88M | 30.06M | 23.44M | 9.34M | 1.74M | |
| 58.88M | 30.06M | 23.44M | 9.34M | 1.74M | |
| -44.25M | -58.15M | -49.86M | -28.75M | -43.57M | |
| -32.18M | -57.76M | -50.33M | -27.94M | -41.85M | |
| -0.64 | -1.73 | -1.98 | -1.34 | -2.28 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 43.92M | 13.38M | 67.91M | 34.96M | 16.25M | |
| 379.85M | 286.69M | 255.90M | 144.09M | 54.09M | |
| 51.91M | 107.27M | 135.00M | 81.93M | 24.62M | |
| 9.91M | 14.22M | 19.63M | 22.60M | 16.36M | |
| 327.94M | 179.42M | 120.90M | 62.16M | 29.47M |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -79.01M | -43.75M | -15.25M | 30.08M | -35.35M | |
| -55.56M | -113.35M | -52.48M | -72.82M | 16.76M | |
| 165.12M | 102.69M | 100.76M | 61.38M | 24.25M | |
| -487.00K | -412.00K | -118.00K | -802.00K | -821.00K | |
| 30.56M | -54.53M | 32.95M | 18.70M | 5.67M |